GUTS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
19.1M
-8.3%
20.8M
-10.6%
23.3M
+2.6%
22.7M
-13.0%
26.1M
R&D
13.8M
-11.5%
15.6M
-5.4%
16.5M
-5.5%
17.5M
-17.5%
21.2M
SG&A
5.3M
+1.2%
5.2M
-23.1%
6.8M
+29.7%
5.2M
+6.3%
4.9M
Operating Income
-19096000
+8.3%
-20820000
+10.6%
-23284000
-2.6%
-22694000
+13.0%
-26079000
EBITDA
-18818000
+8.4%
-20539000
+10.7%
-23005000
-2.7%
-22404000
+13.2%
-25809000
Net Income
-25538000
-377.0%
9.2M
+121.1%
-43727000
+4.1%
-45603000
-63.5%
-27889000
EPS (Basic)
$-0.16
-366.7%
$0.06
+119.4%
$-0.31
+56.3%
$-0.71
-24.6%
$-0.57
EPS (Diluted)
$-0.16
-366.7%
$0.06
+119.4%
$-0.31
+56.3%
$-0.71
-24.6%
$-0.57
Shares (Diluted)
158.6M
+0.1%
158.5M
+12.6%
140.7M
+117.7%
64.7M
+31.8%
49.0M
Fractyl Health (GUTS) โ€” Financials